Wednesday, February 10, 2010, 4:30am EST - Canadian Markets open in 5 hours.
To create a watchlist or portfolio of shares, Sign-in or Register

La Jolla Pharmaceutical Co. (LJPC)

 On Feb 9: 0.1239 USD   0.00 (0.00%)  
MORE ON LJPC
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
La Jolla Pharmaceutical Company (NCM:LJPC) Delayed quote dataEdit
Last Trade: 0.1239 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.1239
Open: N/A
Bid: 0.04 x 25000
Ask: 0.19 x 500
1y Target Est: 6.30
Day's Range: N/A - N/A
52wk Range: 0.04 - 2.36
Volume: 0
Avg Vol (3m): 5,168,190
Market Cap: 8.14M
P/E (ttm): N/A
EPS (ttm): -0.397
Div & Yield: N/A (N/A%)
La Jolla Pharmaceutical Co. (LJPC)
1d  5d  3m  6m  1y  2y  5y  max 
 Add LJPC to Portfolio   Download Data

HEADLINES
• Why I'm Down More Than 80%, and How You Can Avoid My Mistakes
at Motley Fool (Sat, Jan 30)
• LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
EDGAR Online (Mon, Jan 25)
• La Jolla Pharmaceutical Company Receives Nasdaq Delisting Notice and Intends to Appeal Determination
Business Wire (Mon, Jan 25)
• LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events
EDGAR Online (Tue, Dec 22)
• La Jolla Pharmaceutical Company Announces Filing of Joint Proxy Statement/Prospectus
Business Wire (Tue, Dec 22)
• Why We Love Wild Penny Stocks
at Motley Fool (Thu, Dec 10)
• LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pri
EDGAR Online (Mon, Dec 7)
• Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
Business Wire (Mon, Dec 7)
• La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
Business Wire (Mon, Dec 7)
• La Jolla Pharma axes plan to dissolve company
AP (Wed, Nov 25)
More Headlines for LJPC...
ANALYST
EPS Est (next year) (Dec-08) : N/A
EPS Est (in 2 years) (Dec-09) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
La Jolla Pharmaceutical Company, a biopharmaceutical company, engages in the discovery and development of orally-active small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices